417 related articles for article (PubMed ID: 20050006)
1. Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.
Lopes CD; Silva NM; Ferro EA; Sousa RA; Firminot ML; Bernardes ES; Roque-Barreira MC; Pena JD
J Parasitol; 2009 Aug; 95(4):1005-10. PubMed ID: 20050006
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of vertical transmission of Toxoplasma gondii in Calomys callosus model after reinfection with heterologous and virulent strain.
Franco PS; Silva DA; Costa IN; Gomes AO; Silva AL; Pena JD; Mineo JR; Ferro EA
Placenta; 2011 Feb; 32(2):116-20. PubMed ID: 21146211
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to vertical transmission of Toxoplasma gondii is temporally dependent on the preconceptional infection in Calomys callosus.
Barbosa BF; Silva DA; Costa IN; Pena JD; Mineo JR; Ferro EA
Placenta; 2007 Jul; 28(7):624-30. PubMed ID: 17182099
[TBL] [Abstract][Full Text] [Related]
5. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
6. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis.
Lahmar I; Guinard M; Sauer A; Marcellin L; Abdelrahman T; Roux M; Mousli M; Moussa A; Babba H; Pfaff AW; Candolfi E
Exp Parasitol; 2010 Feb; 124(2):190-6. PubMed ID: 19755119
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Toxoplasma gondii placental transmission in BALB/c mice model.
Pezerico SB; Langoni H; Da Silva AV; Da Silva RC
Exp Parasitol; 2009 Oct; 123(2):168-72. PubMed ID: 19563804
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF-alpha and IFN-gamma.
Gazzinelli RT; Brézin A; Li Q; Nussenblatt RB; Chan CC
Exp Parasitol; 1994 Mar; 78(2):217-29. PubMed ID: 8119376
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.
Wei HX; Wei SS; Lindsay DS; Peng HJ
PLoS One; 2015; 10(9):e0138204. PubMed ID: 26394212
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
Kaye A
J Pediatr Health Care; 2011; 25(6):355-64. PubMed ID: 22018426
[TBL] [Abstract][Full Text] [Related]
11. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys.
Schoondermark-van de Ven EM; Melchers WJ; Galama JM; Meuwissen JH; Eskes TK
Eur J Obstet Gynecol Reprod Biol; 1997 Aug; 74(2):183-8. PubMed ID: 9306115
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
14. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
[TBL] [Abstract][Full Text] [Related]
15. [Congenital toxoplasmosis retinochoroiditis after primary infection of the mother in pregnancy].
Kuchar A; Hayde M; Steinkogler FJ
Ophthalmologe; 1996 Apr; 93(2):190-3. PubMed ID: 8652987
[TBL] [Abstract][Full Text] [Related]
16. Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.
Conceição AR; Belucik DN; Missio L; Gustavo Brenner L; Henrique Monteiro M; Ribeiro KS; Costa DF; Valadão MCDS; Commodaro AG; de Oliveira Dias JR; Belfort R
Ophthalmology; 2021 Sep; 128(9):1346-1355. PubMed ID: 33711379
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
20. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.
Schoondermark-van de Ven E; Galama J; Vree T; Camps W; Baars I; Eskes T; Meuwissen J; Melchers W
Antimicrob Agents Chemother; 1995 Jan; 39(1):137-44. PubMed ID: 7695295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
